Novo Holdings To Boost Quantum Technology Development With $200 Million Investment

In the last few years, quantum technology has garnered a lot of interest from businesses across various sectors. From quantum computing to quantum simulation, this advanced technology shows great promise in its problem-solving abilities, being able to compute a lot faster than traditional computers.

Moreover, with the added capabilities brought in by artificial intelligence (AI), quantum computing is set to revolutionize numerous industries and offer a windfall of benefits.

This includes the ability to boost research and development (R&D) efforts for life sciences, healthcare and pharmaceutical sectors.

Recognizing the potential of the technology, Novo Holdings, the holding and investment company behind managing the assets and wealth of the Novo Nordisk Foundation, has made an announcement that’s set to boost quantum technology R&D efforts, especially in the Nordic countries.

So, what did the company say? Let’s explore!
 

What Did Novo Holdings Announce?

 

• As per a news release published on its website, Novo Holdings, a company wholly owned by the Novo Nordisk Foundation, announced that it was committing DKK 1.2 billion (Danish Krone) (€188 million or $200 million) to build a quantum technology start-up ecosystem.

• Founded in 1924, the Novo Nordisk Foundation has been engaged in the pursuit of improving “people’s health and the sustainability of society and the planet” and is known for producing the popular Wegovy (obesity drug) and Ozempic (diabetes treatment).

• The plan is to invest in, support and advance promising quantum technology companies and startups globally, with a focus on Denmark, where the company has its headquarters.

• According to the company, Denmark has been identified as a promising quantum technology hub that’s in need of “a vibrant seed and venture capital investment ecosystem”, which is what Novo Holding’s move aims to offer.

• As per the release, “The quantum industry, which develops novel technologies such as quantum computers or quantum sensing based on quantum physics, holds the potential to dramatically impact a number of industries, and in particular the life sciences.”

• The process will include Quantum Investments anchored with Seed Investments. “The Quantum Investments team will focus on quantum computing, sensing, and algorithms – all areas that have relevant applications within healthcare, and a significant applicability within the broader life sciences sector.”

• The move also aligns with other initiative taken by the company, including the Novo Nordisk Foundation Quantum Computing Programme (NQCP), which “aims to establish one of the world’s first fully functional and generally applicable quantum computers”, as well as The Quantum Foundry, which focuses on developing quantum materials.

• In addition to Novo Holding’s move, the Danish government has also committed to invest DKK 1.2 billion (Danish Krone) (€160 million or $172 million) toward the same cause.

 

What Did Novo Holdings Executives Say?

 

• Søren Møller, Managing Partner, Seed Investments, Novo Holdings, said, “Quantum technology is a disruptive and transformative field that can revolutionise various sectors and address global challenges.”

• [Contd.] “Combining Novo Holdings’ longstanding experience in developing the life sciences ecosystem in the Nordics with the quantum activities and commitment from the Novo Nordisk Foundation provides a very powerful platform for building quantum startups. Our ultimate goal is to create, grow and develop strong quantum technology companies in the Nordics.”

• Lene Oddershede, SVP, Natural & Technical Sciences, Novo Nordisk Foundation, said, “There is a substantial demand for investments in the quantum space to harvest the potential of the emerging quantum technologies.”

• [Contd.] “A strong quantum ecosystem based on knowledge, networks comprised by all relevant partners, and with sufficient capital is instrumental to guarantee the further development and commercialisation of quantum research enabled by the Novo Nordisk Foundation, the Danish state, and the BioInnovation Institute’s (BII) Deep Tech Lab - Quantum.”

• [Contd.] “We foresee significant developments in this area, both imminently and over a longer horizon. Success, however, hinges on our ability to fully leverage the potential of the quantum technologies by realising the full value chain and establishing robust partnerships.”

Do you think Novo Holdings’ move will inspire other companies and investment firms to make similar moves?

Let us know in the comments below!